Legato Capital Management »

Silverback Therapeutics shares owned by Legato Capital Management

Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Legato Capital Management from 13F filings

Historical chart of Legato Capital Management investment in Silverback Therapeutics

Oct 62024Oct 20Nov 3Nov 17Dec 1Dec 15Dec 29250k300k350k22k23k24k
Value ($)Share countHistorical SPRY position of Legato Capital Management Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Silverback Therapeutics held by Legato Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silverback Therapeutics by Legato Capital Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $226k 22k 10.55
2024-09-30 $353k 24k 14.50

More positions owned by Legato Capital Management

Argan (AGX)
Agilysys (AGYS)
UFP Technologies (UFPT)
Stonex Group (SNEX)
Ies Hldgs (IESC)
Bgc Group Inc Cl A (BGC)
Apple (AAPL)
LSI Industries (LYTS)
Broadcom (AVGO)
ePlus (PLUS)
Triumph Ban (TFIN)
Winmark Corporation (WINA)
Daily Journal Corporation (DJCO)
VSE Corporation (VSEC)
Kornit Digital (KRNT)

View all positions for Legato Capital Management

Top funds holding Silverback Therapeutics

RA Capital Management
Deerfield Management Company
OrbiMed Advisors
BlackRock
Sr One Capital Management
Alliancebernstein
Vanguard Group
State Street Corporation
Franklin Resources
Alyeska Investment Group
Geode Capital Management
Woodline Partners
Nextech Invest
FMR
Citadel Advisors

View all funds holding Silverback Therapeutics